Search the site

Register your interest to participate in a FREE pilot excursion for our brand-new program, Microscopic World!

Changes in airway inflammation with pseudomonas eradication in early cystic fibrosis

Changes in airway inflammation with pseudomonas eradication in early cystic fibrosis Background: Neutrophil elastase is a significant risk factor for

Self-harm

Young people provided information on self-harm behaviours of deliberately hurting or injuring yourself without trying to end your life.

Meningococcal Disease

MenABCWY QUINTET Study Meningococcal disease is a rare but serious disease that can result in death if not recognised and treated quickly. There are

Antenatal Sample Collection

Instructions on the various antenatal samples collected by the Origins project and how to collect them.

Five-Year Sample Collection

Get in Touch Dropping off a sample or attending a Kids Check appointment? Visit us at our Edgewater clinic. The Kids Joondalup Shop 51, Joondalup

Families

At The Kids Research Institute Australia our researchers are searching for answers to improve the health and wellbeing of children and families.

The Kids Research Institute Australia leads WA arm of Australia’s first needle-free COVID-19 vaccine study

Enrolments for Australia’s first needle-free, gene-based COVID-19 vaccine study – to be led in WA by The Kids Research Institute Australia – are open.

Key appointments to drive early childhood collaboration

Leading child health researcher Professor Donna Cross has been appointed as Director of the new Early Childhood Development and Learning Collaboration, hosted b

The value of molecular point-of-care testing for Group A Streptococcal pharyngitis in a remote, non-clinical Australian setting

Group A Streptococcal (GAS) pharyngitis is an important precursor infection to severe complications including rheumatic fever and invasive GAS. Rapid molecular point of care testing (POCT) for GAS infection has advantages over traditional microbiological culture, especially in settings with limited or absent laboratory infrastructure and where GAS complications predominate.